Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 197

    1.

    Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.

    Baietto L, D'Avolio A, De Rosa FG, Garazzino S, Michelazzo M, Ventimiglia G, Siccardi M, Simiele M, Sciandra M, Di Perri G.

    Anal Bioanal Chem. 2009 Nov 9. [Epub ahead of print]PMID: 19898996 [PubMed - as supplied by publisher]Related articles

    2.

    Early experience with high-dosage daptomycin for prosthetic infections.

    De Rosa FG, Mollaretti O, Cometto C, Pagani N, Montrucchio C, Di Perri G.

    Clin Infect Dis. 2009 Dec 1;49(11):1772-3. No abstract available. PMID: 19891570 [PubMed - in process]Related articles

    3.

    Management of H1N1 influenza virus respiratory syndrome.

    De Rosa FG, Montrucchio C, Di Perri G.

    Minerva Anestesiol. 2009 Nov;75(11):654-60.PMID: 19881461 [PubMed - in process]Related articlesFree article

    4.

    When and how to use maraviroc in HIV-infected patients.

    Soriano V, Perno CF, Kaiser R, Calvez V, Gatell JM, di Perri G, Pillay D, Rockstroh J, Geretti AM.

    AIDS. 2009 Nov 27;23(18):2377-85. No abstract available. PMID: 19834318 [PubMed - in process]Related articles

    5.

    [HIV infection: treatment of naive patients]

    Bonora S, Calcagno A, Di Perri G.

    Infez Med. 2009 Jun;17(2):69-81. Review. Italian. PMID: 19602919 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report.

    De Rosa FG, Terragni P, Pasero D, Trompeo AC, Urbino R, Barbui A, Di Perri G, Marco Ranieri V.

    Intensive Care Med. 2009 Sep;35(9):1641-3. Epub 2009 Jun 16. No abstract available. PMID: 19529909 [PubMed - in process]Related articles

    7.

    Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy.

    Antinori A, Ammassari A, Torti C, Marconi P, Andreoni M, Angarano G, Bonora S, Castagna A, Cauda R, Clerici M, Monforte A, De Luca A, Di Perri G, Galli M, Girardi E, Gori A, Lazzarin A, Lo Caputo S, Mazzotta F, Montella F, Mussini C, Perno CF, Puoti M, Rizzardini G, Rusconi S, Vullo V, Carosi G.

    Infection. 2009 Jun;37(3):270-82. Epub 2009 May 28.PMID: 19479193 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.

    Torti C, Lapadula G, Antinori A, Quirino T, Maserati R, Castelnuovo F, Maggiolo F, De Luca A, Paraninfo G, Antonucci F, Migliorino G, Lazzarin A, Di Perri G, Rizzardini G, Esposito R, Carosi G.

    Infection. 2009 Jun;37(3):244-9. Epub 2009 May 26.PMID: 19471856 [PubMed - indexed for MEDLINE]Related articles

    9.

    New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.

    De Francia S, D'Avolio A, De Martino F, Pirro E, Baietto L, Siccardi M, Simiele M, Racca S, Saglio G, Di Carlo F, Di Perri G.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Jun 15;877(18-19):1721-6. Epub 2009 Apr 24.PMID: 19428316 [PubMed - indexed for MEDLINE]Related articles

    10.

    Interactions between antiretroviral agents and those used to treat tuberculosis.

    Bonora S, Di Perri G.

    Curr Opin HIV AIDS. 2008 May;3(3):306-12.PMID: 19372983 [PubMed]Related articles

    11.

    Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.

    van Luin M, Bannister WP, Mocroft A, Reiss P, Di Perri G, Peytavin G, Molto J, Karlson A, Castagna A, Beniowski M, Lundgren JD, Burger DM; EuroSIDA Study Group.

    Antivir Ther. 2009;14(1):75-83.PMID: 19320239 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention and diagnosis of ventilator-associated pneumonia: a regional survey in Italy.

    De Rosa FG, Michelazzo M, Pagani N, Di Perri G, Ranieri VM, Barberis B.

    Chest. 2009 Mar;135(3):881-2. No abstract available. PMID: 19265103 [PubMed - indexed for MEDLINE]Related articles

    13.

    Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.

    Santoro MM, Bertoli A, Lorenzini P, Ceccherini-Silberstein F, Gianotti N, Mussini C, Torti C, Di Perri G, Barbarini G, Bini T, Melzi S, Caramello P, Maserati R, Narciso P, Micheli V, Antinori A, Perno CF; CARe Study Group.

    Infection. 2009 Jun;37(3):233-43. Epub 2009 Jan 23.PMID: 19169632 [PubMed - indexed for MEDLINE]Related articles

    14.

    Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.

    Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M.

    J Med Virol. 2009 Mar;81(3):400-5.PMID: 19152404 [PubMed - indexed for MEDLINE]Related articles

    15.

    Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

    Svicher V, Alteri C, D'Arrigo R, Laganà A, Trignetti M, Lo Caputo S, Callegaro AP, Maggiolo F, Mazzotta F, Ferro A, Dimonte S, Aquaro S, di Perri G, Bonora S, Tommasi C, Trotta MP, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F.

    Antimicrob Agents Chemother. 2009 Jul;53(7):2816-23. Epub 2009 Jan 5.PMID: 19124665 [PubMed - indexed for MEDLINE]Related articles

    16.

    Invasive candidiasis and candidemia: new guidelines.

    De Rosa FG, Garazzino S, Pasero D, Di Perri G, Ranieri VM.

    Minerva Anestesiol. 2009 Jul-Aug;75(7-8):453-8. Epub 2008 Jan 24. Review.PMID: 19078900 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.

    Baietto L, D'Avolio A, De Rosa FG, Garazzino S, Patanella S, Siccardi M, Sciandra M, Di Perri G.

    Ther Drug Monit. 2009 Feb;31(1):104-9.PMID: 19077929 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

    Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Massè A, Di Perri G.

    Clin Pharmacokinet. 2008;47(12):793-805. doi: 10.2165/0003088-200847120-00004.PMID: 19026035 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.

    Siccardi M, D'Avolio A, Baietto L, Gibbons S, Sciandra M, Colucci D, Bonora S, Khoo S, Back DJ, Di Perri G, Owen A.

    Clin Infect Dis. 2008 Nov 1;47(9):1222-5.PMID: 18831695 [PubMed - indexed for MEDLINE]Related articles

    20.

    An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.

    D'Avolio A, Baietto L, Siccardi M, Sciandra M, Simiele M, Oddone V, Bonora S, Di Perri G.

    Ther Drug Monit. 2008 Dec;30(6):662-9.PMID: 18824956 [PubMed - indexed for MEDLINE]Related articles

    21.

    Post-traumatic osteomyelitis due to Aspergillus flavus successfully treated with voriconazole: a case report.

    Garazzino S, Maiello A, DE Rosa FG, Aprato A, Di Perri G.

    J Chemother. 2008 Aug;20(4):524-6. No abstract available. PMID: 18676238 [PubMed - indexed for MEDLINE]Related articles

    22.

    A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.

    D'Avolio A, Sciandra M, Siccardi M, Baietto L, Gonzalez de Requena D, Bonora S, Di Perri G.

    J Chromatogr Sci. 2008 Jul;46(6):524-8. Erratum in: J Chromatogr Sci. 2008 Sep;46(8):8A. PMID: 18647474 [PubMed - indexed for MEDLINE]Related articles

    23.

    Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.

    Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G, Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C.

    J Antimicrob Chemother. 2008 Nov;62(5):1113-7. Epub 2008 Jul 18.PMID: 18641036 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Performance and costs of a rapid syphilis test in an urban population at high risk for sexually transmitted infections.

    Gianino MM, Dal Conte I, Sciolè K, Galzerano M, Castelli L, Zerbi R, Arnaudo I, Di Perri G, Renga G.

    J Prev Med Hyg. 2007 Dec;48(4):118-22.PMID: 18557305 [PubMed - indexed for MEDLINE]Related articles

    25.

    Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.

    Bonora S, Mondo A, Trentini L, Calcagno A, Lucchini A, Di Perri G.

    J Infect. 2008 Jul;57(1):78-81. Epub 2008 Jun 11.PMID: 18550175 [PubMed - indexed for MEDLINE]Related articles

    26.

    Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

    de Requena DG, Bonora S, Castagna A, Hasson H, Marucco DA, D'Avolio A, Sciandra M, Trentini L, Calcagno A, Lazzarin A, Di Perri G.

    J Antimicrob Chemother. 2008 Aug;62(2):384-7. Epub 2008 May 16.PMID: 18487231 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens.

    Nicastri E, Palmisano L, Sarmati L, D'Ettorre G, Parisi S, Andreotti M, Buonomini A, Pirillo FM, Narciso P, Bellagamba R, Vullo V, Montano M, Di Perri G, Andreoni M.

    Curr HIV Res. 2008 May;6(3):261-6.PMID: 18473790 [PubMed - indexed for MEDLINE]Related articles

    28.

    SPIR01 and SPIR02: a two-year 1-day point prevalence multicenter study of infections in intensive care units in Piedmont, Italy.

    De Rosa FG, Garazzino S, Audagnotto S, Bargiacchi O, Zeme DA, Gramoni A, Barberis B, Ranieri VM, Di Perri G; Piedmont Intensive Care Unit Network.

    New Microbiol. 2008 Jan;31(1):81-7.PMID: 18437845 [PubMed - indexed for MEDLINE]Related articles

    29.

    Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure.

    Svicher V, Aquaro S, D'Arrigo R, Artese A, Dimonte S, Alcaro S, Santoro MM, Di Perri G, Caputo SL, Bellagamba R, Zaccarelli M, Visco-Comandini U, Antinori A, Narciso P, Ceccherini-Silberstein F, Perno CF.

    J Infect Dis. 2008 May 15;197(10):1408-18.PMID: 18419549 [PubMed - indexed for MEDLINE]Related articles

    30.

    Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?

    Maggi P, Filotico R, Bonora S, Volpe A, Bellacosa C, Cinori E, de Requena DG, D'Avolio A, Di Perri G.

    Clin Drug Investig. 2008;28(5):305-11. Review.PMID: 18407716 [PubMed - indexed for MEDLINE]Related articles

    31.

    [Relapsing infection of cranial prosthesis sustained by Enterobacter cloacae and methicillin-resistant Staphylococcus aureus]

    Garazzino S, De Rosa FG, Bargiacchi O, Di Perri G.

    Infez Med. 2008 Mar;16(1):43-6. Italian. PMID: 18367884 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.

    Aguilar Marucco D, Gonzalez de Requena D, Bonora S, Tettoni C, Bonasso M, De Blasi T, D'Avolio A, Sciandra M, Siccardi M, Baietto L, Trentini L, Sinicco A, Cariti G, Di Perri G.

    J Antimicrob Chemother. 2008 Apr;61(4):919-24. Epub 2008 Jan 31.PMID: 18238889 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.

    D'Avolio A, Baietto L, De Rosa FG, Garazzino S, Sciandra M, Siccardi M, Bonora S, Di Perri G.

    Ther Drug Monit. 2008 Feb;30(1):90-4.PMID: 18223468 [PubMed - indexed for MEDLINE]Related articles

    34.

    Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.

    Bonora S, Calcagno A, Fontana S, D'Avolio A, Siccardi M, Gobbi F, Di Perri G.

    Clin Infect Dis. 2007 Dec 15;45(12):1654-5. No abstract available. PMID: 18190336 [PubMed - indexed for MEDLINE]Related articles

    35.

    Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment.

    Bonora S, Lanzafame M, D'Avolio A, Trentini L, Lattuada E, Concia E, Di Perri G.

    Clin Infect Dis. 2008 Jan 1;46(1):146-7. No abstract available. PMID: 18171231 [PubMed - indexed for MEDLINE]Related articles

    36.

    Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.

    de Requena DG, Bonora S, Calcagno A, D'Avolio A, Siccardi M, Fontana S, Milia MG, Sciandra M, Garazzino S, Di Garbo A, Baietto L, Trentini L, Di Perri G.

    Antimicrob Agents Chemother. 2008 Mar;52(3):1066-71. Epub 2007 Dec 26.PMID: 18160524 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.

    Santoro MM, Bertoli A, Lorenzini P, Lazzarin A, Esposito R, Carosi G, Di Perri G, Filice G, Moroni M, Rizzardini G, Caramello P, Maserati R, Narciso P, Cargnel A, Antinori A, Perno CF; CARe Study Group.

    AIDS Patient Care STDS. 2008 Jan;22(1):7-16.PMID: 18095835 [PubMed - indexed for MEDLINE]Related articles

    38.

    HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.

    D'Avolio A, Siccardi M, Sciandra M, Baietto L, Bonora S, Trentini L, Di Perri G.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):234-40. Epub 2007 Oct 7. Erratum in: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 1;862(1-2):265. Lorena, Baietto [corrected to Baietto, Lorena]. PMID: 17964231 [PubMed - indexed for MEDLINE]Related articles

    39.

    Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b.

    De Blasi T, Aguilar Marucco D, Cariti G, Maiello A, De Rosa FG, Di Perri G.

    Infection. 2008 Jun;36(3):285-7. Epub 2007 Oct 25.PMID: 17962905 [PubMed - indexed for MEDLINE]Related articles

    40.

    gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure.

    D'Arrigo R, Ciccozzi M, Gori C, Montieri S, Aquaro S, Bellagamba R, Boumis E, Di Perri G, Pizzi D, Antinori A, Rezza G, Perno CF.

    AIDS Res Hum Retroviruses. 2007 Oct;23(10):1296-302.PMID: 17961119 [PubMed - indexed for MEDLINE]Related articles

    41.

    Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users.

    De Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Cariti G, Calleri G, Lesioba O, Belloro S, Raiteri R, Di Perri G.

    Clin Infect Dis. 2007 Sep 1;45(5):583-8. Epub 2007 Jul 19.PMID: 17682992 [PubMed - indexed for MEDLINE]Related articles

    42.

    Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients.

    De Rosa FG, Cicalini S, Canta F, Audagnotto S, Cecchi E, Di Perri G.

    Infection. 2007 Jun;35(3):154-60.PMID: 17565456 [PubMed - indexed for MEDLINE]Related articles

    43.

    First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).

    Carosi G, Quiros-Roldan E, Torti C, Antinori A, Bevilacqua M, Bonadonna RC, Bonfanti P, Castagna A, Cauda R, d'Arminio-Monforte A, Di Gregorio P, Di Perri G, Esposito R, Fatuzzo F, Gervasoni C, Giannattasio C, Guaraldi G, Lazzarin A, Lo Caputo S, Maggi P, Mazzotta F, Moroni M, Prestileo T, Ranieri R, Rizzardini G, Russo R, Galli M; Members of the Italian Cardiovascular Risk Guidelines Working Group.

    Infection. 2007 Jun;35(3):134-42.PMID: 17565453 [PubMed - indexed for MEDLINE]Related articles

    44.

    Haematological safety of long-term therapy with linezolid.

    Garazzino S, De Rosa FG, Bargiacchi O, Audagnotto S, Maiello A, Di Perri G.

    Int J Antimicrob Agents. 2007 Apr;29(4):480-3. Epub 2007 Feb 20. No abstract available. PMID: 17317112 [PubMed - indexed for MEDLINE]Related articles

    45.

    A short course of pegylated interferon-alpha in acute HCV hepatitis.

    Calleri G, Cariti G, Gaiottino F, De Rosa FG, Bargiacchi O, Audagnotto S, Quaglia S, De Blasi T, Romano P, Traverso A, Leo G, Carbone R, Del Mastro B, Tinelli M, Caramello P, Di Perri G.

    J Viral Hepat. 2007 Feb;14(2):116-21.PMID: 17244251 [PubMed - indexed for MEDLINE]Related articles

    46.

    Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus.

    Aguilar Marucco D, Veronese L, de Requena DG, Bonora S, Calcagno A, Cavecchia I, Sinicco A, De Rosa FG, Cariti G, Di Perri G.

    J Antimicrob Chemother. 2007 Mar;59(3):565-8. Epub 2007 Jan 9.PMID: 17213263 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.

    Simpson JA, Agbenyega T, Barnes KI, Di Perri G, Folb P, Gomes M, Krishna S, Krudsood S, Looareesuwan S, Mansor S, McIlleron H, Miller R, Molyneux M, Mwenechanya J, Navaratnam V, Nosten F, Olliaro P, Pang L, Ribeiro I, Tembo M, van Vugt M, Ward S, Weerasuriya K, Win K, White NJ.

    PLoS Med. 2006 Nov;3(11):e444.PMID: 17132053 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.

    D'Avolio A, Sciandra M, Siccardi M, Baietto L, de Requena DG, Bonora S, Di Perri G.

    J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):374-8. Epub 2006 Nov 7.PMID: 17092784 [PubMed - indexed for MEDLINE]Related articles

    49.

    Continuous infusion of amphotericin B deoxycholate: does decreased nephrotoxicity couple with time-dependent pharmacodynamics?

    de Rosa FG, Bargiacchi O, Audagnotto S, Garazzino S, Ranieri VM, di Perri G.

    Leuk Lymphoma. 2006 Sep;47(9):1964-6. Review. No abstract available. PMID: 17065014 [PubMed - indexed for MEDLINE]Related articles

    50.

    Disseminated gonococcal infection in an immunocompetent patient caused by an imported Neisseria gonorrhoeae multidrug-resistant strain.

    Dal Conte I, Starnino S, Di Perri G, Stefanelli P.

    J Clin Microbiol. 2006 Oct;44(10):3833-4.PMID: 17021122 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...